The National Industrial Hemp Council (NIHC) filed comments on August 19, 2020 with the Food And Drug Administration (FDA) to help direct their work on establishing a policy of enforcement discretion on CBD products.

The comments were filed after the NIHC participated in a listening session with the FDA’s CBD Working Group on July 27 in which members of NIHC’s Consumer Protection Task Force emphasized the importance of establishing basic safety standards to protect consumers in this nascent industry and committed to follow up in writing with detailed policy recommendations.

You can read the NIHC’s enforcement discretion policy recommendations below.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [819.46 KB]